Global Cold Compression Therapy Market – Industry Trends and Forecast to 2029

Get Exclusive Sample PDF of this Report Here

Market Analysis and Size

Compression therapy has long been a staple of vascular management and wound care for venous insufficiency patients. Cold and compression are commonly used after an acute injury or surgery to relieve pain, reduce swelling, and speed functional recovery. Edema treatment and improved venous return are two of the many advantages of cold compression therapy. Many patients, however, are unable to tolerate the stockings and compression bandages that are usually employed in this therapy.

Data Bridge Market Research analyses that the cold compression therapy market which was USD 3.0 billion in 2021, would rocket up to USD 4.60 billion by 2029, and is expected to undergo a CAGR of 5.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Get Exclusive Sample PDF of this Report Here

Market Definition

Cold compression therapy is a type of treatment for acute injuries that combines the benefits of cold therapy and compression therapy to provide the best pain and swelling relief. It can be used by individuals who are suffering from small joint discomfort to those who are recovering from major surgery. Compression helps to prevent excess swelling and remove unneeded fluid from the wounded area by narrowing blood vessels and reducing blood flow to the affected area and this reduces edoema.

Cold Compression Therapy Market Dynamics

Drivers

• Cold compression therapy benefits

Effects of cold compression therapy fades with time, it is regarded to be most beneficial when used after an accident or at the end of an operational procedure. As a result, controlled trials of acute athletic or trauma-related musculoskeletal injuries are scarce, difficult to execute, and difficult to interpret. As a result, treatment is sometimes haphazard and inexact. On the other hand, the operating context provides a more controlled environment in which to assess the effect of cold compression in the management of post-surgical edoema, pain, and function. As a result, controlled studies have a higher level of methodological quality, and their findings may be more reliable.

• Upsurge in the number of sports injuries and accidents

Cold compression therapy is becoming more popular, such as the increased occurrence of sports injuries, traffic accidents, excessive weight gain or obesity, and the human body's long-term static nature.

• Rise in the aging population

Cold compression therapy is needed in the daily lives of the older population who are suffering from arthritis as a result of the advent of other chronic disorders such as heart disease, diabetes, and obesity.

• Recent technological developments

Wound treatment has seen rapid technological advancements and a growth in the number of preventative and rehabilitative care clinics that use this form of therapy for patients.

Opportunities

The market is predicted to rise due to the rising prevalence of sports injuries and arthritis. For example, the Centers for Disease Control and Prevention (CDC) projected in September 2017 that 3.2 million people aged 5 to 14 years suffer from sports injuries on a yearly basis. As the geriatric population grows, so does the number of joint instability, fractures, and joint diseases like osteoarthritis. These factors also influence the rising demand for hip and knee surgeries, which will drive the use of cold compression therapy products in the coming years. Furthermore, established companies have been emphasising on R&D operations in order to deliver innovative product lines and supporting accessories into the market, resulting in attractive opportunities for this industry.

Restraints/Challenges

The metabolic rate of the soft tissue immediately surrounding the cold application is slowed. This drop in tissue metabolism is accompanied by a decrease in enzymatic activity, which protects tissue against hypoxia-induced damage. Local hypothermia causes vasoconstriction and a 60 percent reduction in microcirculation, which can last up to 30 minutes after cooling is stopped. Extravasation of blood into surrounding tissues, local inflammation, and edoema formation are all reduced by cold-induced vasoconstriction. The reduction in edoema production as well as decreases in motor and sensory nerve conduction contribute to the pain relief associated with direct application of cold to wounded tissue.

This cold compression therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cold compression therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cold Compression Therapy Market

The cold compression therapy market was negatively impacted by COVID-19. The healthcare business is at the centre of a global pandemic threat that is expected to have far-reaching long-term consequences. Once the crisis is under control or subsides, countries and major market players are likely to enact essential healthcare changes. Along with a dramatic reduction in outpatient visits, elective surgeries, and international patients, the private healthcare sector is shouldering twice the weight, investing more staff, equipment, consumables, and other resources to ensure hospital safety and eventual patient treatment. Doctors are being reassigned to treat COVID-19 patients, decreasing their ability to focus on ordinary patients due to the epidemic.

Recent Development

• In March, 2020, SIGVARIS AG, a Swiss compression therapy company, has launched a new line of Coolflex devices to help patients with chronic venous diseases, such as lymphatic abnormalities in the arm, heal more quickly.

Global Cold Compression Therapy Market Scope

The cold compression therapy market is segmented on the basis of technology and product. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Static Compression Therapy
• Dynamic Compression Therapy

Product

• Compression Pumps
• Compression Stockings
• Compression Bandages
• Compression Tapes
• Others

Cold Compression Therapy Market Regional Analysis/Insights

The cold compression therapy market is analysed and market size insights and trends are provided by country, technology and product as referenced above.

The countries covered in the cold compression therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the cold compression therapy market, owing to the presence of factors such as high healthcare expenditure, and rising geriatric population in the U.S.

Asia-Pacific is expected to witness lucrative growth throughout the forecast period 2022 to 2029. The market is driven by an upsurge in investments in R&D by key players as well as increasing disposable income in emerging countries such as India, and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cold Compression Therapy Market Share Analysis

The cold compression therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to cold compression therapy market.

Some of the major players operating in the cold compression therapy market are:

• medi GmbH & Co. KG (Germany)
• Medtronic (Ireland)
• SIGVARIS GROUP (US)
• Juzo (Germany)
• PAUL HARTMANN AG (Germany)
• 3M (US)
• Spectrum Healthcare (India)
• BIOCOMPRESSION SYSTEMS (US)
• Gottfried Medical, Inc. (US)
• BSN medical (Germany)
• Arjo. (Sweden)
• DJO, LLC (US)
• Tactile Medical (US)
• SANYLEG SRL a socio unico (Italy)
• Cardinal Health. (US)
• Devon Medical Products (US)
• THUASNE SAS (US)
• ACI Medical, LLC (US)
• Ofa Bamberg GmbH (Germany)
• Mego Afek A.C. ltd. (Israel)
• Medline Industries, Inc. (US)

SKU-68352